Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-088127
Filing Date
2021-07-01
Accepted
2021-07-01 13:00:59
Documents
1
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121155-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121155-4_4seq1.xml 4 4077
  Complete submission text file 0001104659-21-088127.txt   5747
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Islam Khalid (Reporting) CIK: 0001701858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 211065026